Sun Pharma expects to close the acquisition on or before 31 July 2026.

Welcome to the Sun Pharma Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most ...

Shares of Sun Pharma settled 0.17% lower at Rs 1,935.50 apiece on the NSE. This compared to a 1.02% advance in the benchmark ...

Stock of Sun Pharmaceutical is in focus as the company’s shares are set to turn ex- dividend tomorrow with its final dividend ...

Sun Pharma shares rose 0.65 per cent to close at Rs 1,798.80. At this level, the stock has climbed 4.56 per cent year-to-date (YTD).

Shares of Sun Pharmaceutical Industries Ltd. 524715 rose 2.70% to 1,938.85 Indian rupees Thursday, on what proved to be an all-around favorable trading session for the stock market, with the BSE ...

After a first round of whistleblower allegations prompted Sun Pharma to rally investors for a clarification call, a second complaint has driven immediate changes at the Indian drugmaker. Sun Pharma ...

Get Sun Pharmaceutical Industries latest Profit & Loss account, Income Statement, Financial Statements and Sun Pharmaceutical Industries detailed profit and loss accounts including income, expenses, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Specialty generics company Sun Pharma has completed the merger of Taro. As part of this merger, Sun Pharma acquired all outstanding ordinary shares of Taro other than the shares already held by Sun ...

After navigating a series of manufacturing problems in recent months, Sun Pharma has now been forced to respond to an entirely different type of issue. Last week, Mumbai, India-based Sun Pharma ...